Your browser doesn't support javascript.
loading
YH29407 with anti-PD-1 ameliorates anti-tumor effects via increased T cell functionality and antigen presenting machinery in the tumor microenvironment.
Kim, Dong Kwon; Synn, Chun-Bong; Yang, Seung Min; Kang, Seongsan; Baek, Sujeong; Oh, Se-Woong; Lee, Gyu-Jin; Kang, Ho-Woong; Lee, Young-Sung; Park, Jong Suk; Kim, Jae Hwan; Byeon, Youngseon; Kim, Young Seob; Lee, Doo Jae; Kim, Hyun-Woo; Park, June Dong; Lee, Sung Sook; Lee, Ji Yun; Lee, Jii Bum; Kim, Chang Gon; Hong, Min Hee; Lim, Sun Min; Kim, Hey Ryun; Pyo, Kyoung-Ho; Cho, Byoung Chul.
Affiliation
  • Kim DK; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Synn CB; Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea.
  • Yang SM; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Kang S; Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea.
  • Baek S; Department of Research Support, Yonsei Biomedical Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Oh SW; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi, South Korea.
  • Lee GJ; Department of Research Support, Yonsei Biomedical Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Kang HW; Yuhan R&D Institute, Yuhan Corporation, Seoul, South Korea.
  • Lee YS; Yuhan R&D Institute, Yuhan Corporation, Seoul, South Korea.
  • Park JS; Yuhan R&D Institute, Yuhan Corporation, Seoul, South Korea.
  • Kim JH; Yuhan R&D Institute, Yuhan Corporation, Seoul, South Korea.
  • Byeon Y; Yuhan R&D Institute, Yuhan Corporation, Seoul, South Korea.
  • Kim YS; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Lee DJ; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Kim HW; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Park JD; Wide River Institute of Immunology, Seoul National University, Hongcheon, South Korea.
  • Lee SS; Wide River Institute of Immunology, Seoul National University, Hongcheon, South Korea.
  • Lee JY; Wide River Institute of Immunology, Seoul National University, Hongcheon, South Korea.
  • Lee JB; Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.
  • Kim CG; Department of Hematology-Oncology, Inje University Haeundae Paik Hospital, Busan, Korea.
  • Hong MH; Division of Medical Oncology, Department of Internal Medicine and Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Lim SM; Division of Medical Oncology, Department of Internal Medicine and Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Kim HR; Division of Medical Oncology, Department of Internal Medicine and Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Pyo KH; Division of Medical Oncology, Department of Internal Medicine and Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Cho BC; Division of Medical Oncology, Department of Internal Medicine and Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Front Chem ; 10: 998013, 2022.
Article in En | MEDLINE | ID: mdl-36545214

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Chem Year: 2022 Document type: Article Affiliation country: Corea del Sur Country of publication: Suiza

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Chem Year: 2022 Document type: Article Affiliation country: Corea del Sur Country of publication: Suiza